Overview

Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & Efficacy

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To obtain information on clinical practices for patients treated by Aptivus in real life
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Tipranavir